What gastroenterologists should know during COVID-19 Pandemic!
Copyright: © Pakistan Journal of Medical Sciences..
The WHO has declared a Pandemic due to Novel Corona virus-19 (COVID-19). Patients usually have respiratory symptoms but gastrointestinal and hepatic dysfunction are not uncommon presentations and can lead to a delay in diagnosis and management. Virus shedding can continue even after the nasopharyngeal swab gets negative and could lead to faecal-oral transmission. The effects of COVID-19 on patients with decompensated liver disease is still not clear. Managing immunosuppressive drugs in liver transplant and inflammatory bowel disease is a major challenge without clear guidelines. Only emergency endoscopy is to be done with personal protection equipment. Chloroquine and Hydroxychloroquine has shown some beneficial effects and is being used off-label. Without effective treatment, it is imperative to take precautionary measures.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
Pakistan journal of medical sciences - 36(2020), COVID19-S4 vom: 24. Mai, Seite S124-S125 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kamani, Lubna [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 29.03.2024 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.12669/pjms.36.COVID19-S4.2651 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311607055 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM311607055 | ||
003 | DE-627 | ||
005 | 20240329233043.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.12669/pjms.36.COVID19-S4.2651 |2 doi | |
028 | 5 | 2 | |a pubmed24n1354.xml |
035 | |a (DE-627)NLM311607055 | ||
035 | |a (NLM)32582330 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kamani, Lubna |e verfasserin |4 aut | |
245 | 1 | 0 | |a What gastroenterologists should know during COVID-19 Pandemic! |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright: © Pakistan Journal of Medical Sciences. | ||
520 | |a The WHO has declared a Pandemic due to Novel Corona virus-19 (COVID-19). Patients usually have respiratory symptoms but gastrointestinal and hepatic dysfunction are not uncommon presentations and can lead to a delay in diagnosis and management. Virus shedding can continue even after the nasopharyngeal swab gets negative and could lead to faecal-oral transmission. The effects of COVID-19 on patients with decompensated liver disease is still not clear. Managing immunosuppressive drugs in liver transplant and inflammatory bowel disease is a major challenge without clear guidelines. Only emergency endoscopy is to be done with personal protection equipment. Chloroquine and Hydroxychloroquine has shown some beneficial effects and is being used off-label. Without effective treatment, it is imperative to take precautionary measures | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Corona virus | |
650 | 4 | |a Endoscopy | |
650 | 4 | |a Gastrointestinal | |
650 | 4 | |a Liver | |
773 | 0 | 8 | |i Enthalten in |t Pakistan journal of medical sciences |d 2007 |g 36(2020), COVID19-S4 vom: 24. Mai, Seite S124-S125 |w (DE-627)NLM182942562 |x 1682-024X |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2020 |g number:COVID19-S4 |g day:24 |g month:05 |g pages:S124-S125 |
856 | 4 | 0 | |u http://dx.doi.org/10.12669/pjms.36.COVID19-S4.2651 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2020 |e COVID19-S4 |b 24 |c 05 |h S124-S125 |